Literature DB >> 18692550

Activation of opioid mu-receptor by sinomenine in cell and mice.

Mao Hsien Wang1, Cheng-Kuei Chang, Jun-Hwa Cheng, Hung-Tsung Wu, Ying-Xiao Li, Juei-Tang Cheng.   

Abstract

Sinomenine, one of the alkaloids extracted from roots or stems of Sinomenium acutum, is documented to show antinociceptive action but the action mechanism is still unclear. The present study was aimed to investigate the effect of sinomenine on opioid mu-receptor (OMR). In Chinese Hamster Ovary (CHO) cell transfected with OMR, the binding of [(3)H]naloxone was displaced by sinomenine in a concentration-dependent manner. This compound also raised the phosphorylation of OMR in these cells. In a tail-flick test, sinomenine produced dose-dependent antinociception in mice, which was dose-dependently inhibited by pretreatment of naloxonazine, a selective OMR antagonist. Long-term pretreatment with sinomenine may delay the analgesic tolerance of morphine. The obtained results suggest that sinomenine has an ability to activate OMR, implicating the potential of sinomenine to be applied in clinic.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18692550     DOI: 10.1016/j.neulet.2008.07.088

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  HPLC and LC-MS analysis of sinomenine and its application in pharmacokinetic studies in rats.

Authors:  Li-hong Long; Peng-fei Wu; Xiang-long Chen; Zui Zhang; Yu Chen; Yi-yong Li; You Jin; Jian-guo Chen; Fang Wang
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

2.  Sinomenine inhibits microglial activation by Aβ and confers neuroprotection.

Authors:  Shilpa Mishra Shukla; Shiv K Sharma
Journal:  J Neuroinflammation       Date:  2011-09-14       Impact factor: 8.322

Review 3.  Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Authors:  Wei Jiang; Mingze Tang; Limin Yang; Xu Zhao; Jun Gao; Yue Jiao; Tao Li; Cai Tie; Tianle Gao; Yanxing Han; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

4.  Effect of Sinomenine on the Morphine-Dependence and Related Neural Mechanisms in Mice.

Authors:  Miao Fang; Junkui Li; Daoqi Zhu; Chaohua Luo; Chan Li; Chen Zhu; Menglin Fan; Ken Kin-Lam Yung; Zhixian Mo
Journal:  Neurochem Res       Date:  2017-11-08       Impact factor: 3.996

5.  Antinociceptive effects of sinomenine in a rat model of neuropathic pain.

Authors:  Qing Zhu; Yuehua Sun; Jie Zhu; Tian Fang; Wei Zhang; Jun-Xu Li
Journal:  Sci Rep       Date:  2014-12-01       Impact factor: 4.379

6.  In silico design of novel probes for the atypical opioid receptor MRGPRX2.

Authors:  Katherine Lansu; Joel Karpiak; Jing Liu; Xi-Ping Huang; John D McCorvy; Wesley K Kroeze; Tao Che; Hiroshi Nagase; Frank I Carroll; Jian Jin; Brian K Shoichet; Bryan L Roth
Journal:  Nat Chem Biol       Date:  2017-03-13       Impact factor: 15.040

Review 7.  Analgesic Mechanism of Sinomenine against Chronic Pain.

Authors:  Wei Jiang; Weiming Fan; Tianle Gao; Tao Li; Zhenming Yin; Huihui Guo; Lulu Wang; Yanxing Han; Jian-Dong Jiang
Journal:  Pain Res Manag       Date:  2020-05-06       Impact factor: 3.037

8.  N-Demethylsinomenine, an active metabolite of sinomenine, attenuates chronic neuropathic and inflammatory pain in mice.

Authors:  Zhiyong Zhou; Nanqing Qiu; Yuntao Ou; Qianqian Wei; Wenting Tang; Mingcong Zheng; Yaluan Xing; Jie-Jia Li; Yong Ling; Junxu Li; Qing Zhu
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

9.  RIP3 Inhibition ameliorates chronic constriction injury-induced neuropathic pain by suppressing JNK signaling.

Authors:  Na He; Yu-Juan Qu; Dan-Yang Li; Shou-Wei Yue
Journal:  Aging (Albany NY)       Date:  2021-11-12       Impact factor: 5.682

10.  MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study.

Authors:  X Li; K Wang; Y Ren; L Zhang; X-J Tang; H-M Zhang; C-Q Zhao; P-J Liu; J-M Zhang; J-J He
Journal:  Cell Death Dis       Date:  2014-07-31       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.